NOVARTIS PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at NOVARTIS PHARMACEUTICALS is $127,982, based on 584 certified filings from FY 2020 to FY 2026. This is 7% higher than the national H-1B median salary of $120,000. Compensation at NOVARTIS PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $104,603 and senior positions reaching $174,096 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at NOVARTIS PHARMACEUTICALS range from $88,962 at the 10th percentile to $174,096 at the 90th percentile, showing a $85,134 spread across experience levels and roles. The 25th percentile is $104,603 and the 75th percentile is $153,171.

Yes, NOVARTIS PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 591 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 584 certified applications and a 0% denial rate, NOVARTIS PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), NOVARTIS PHARMACEUTICALS filed 15 H-1B applications, with 15 certified and 0 denied. Over 7 years of data, NOVARTIS PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

NOVARTIS PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 591 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating NOVARTIS PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating NOVARTIS PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

NOVARTIS PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 584 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles NOVARTIS PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at NOVARTIS PHARMACEUTICALS:

The most frequently sponsored role is Principal Biostatistician with 76 filings at a median salary of $109,824. This is followed by Senior Principal Biostatistician (31 filings) and Associate Data Scientist.

NOVARTIS PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where NOVARTIS PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top NOVARTIS PHARMACEUTICALS H-1B locations:

The largest H-1B hub for NOVARTIS PHARMACEUTICALS is East Hanover, NJ with 486 filings at a median salary of $134,763. The highest-paying location is East Hanover, NJ at $134,763 median. Salaries range from $81,931 to $134,763 across office locations.

NOVARTIS PHARMACEUTICALS's median H-1B salary has increased by +66% from FY 2020 ($102,024) to FY 2026 ($169,541). Tracking salary trends over time reveals how NOVARTIS PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at NOVARTIS PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $123,864 (76 certified)
• FY 2023: $127,650 (93 certified)
• FY 2024: $136,219 (90 certified)
• FY 2025: $142,771 (112 certified)
• FY 2026: $169,541 (15 certified)

This 66% growth reflects strong compensation adjustments at NOVARTIS PHARMACEUTICALS, keeping pace with market demands for H-1B talent.

NOVARTIS PHARMACEUTICALS primarily files H-1B applications at Wage Level IV, accounting for 34% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making NOVARTIS PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 93% of positions at Level II or higher, NOVARTIS PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

NOVARTIS PHARMACEUTICALS's median H-1B salary of $127,982 is 7% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating NOVARTIS PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare NOVARTIS PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

NOVARTIS PHARMACEUTICALS offers above-average H-1B compensation. Combined with their 584 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. NOVARTIS PHARMACEUTICALS's higher proportion of Level III-IV positions (65%) may benefit from wage-based lottery prioritization.

With 584 certified filings, NOVARTIS PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.